212 related articles for article (PubMed ID: 31209006)
1. Pharmacodynamics of Isavuconazole in a Rabbit Model of Cryptococcal Meningoencephalitis.
Kovanda LL; Giamberardino C; McEntee L; Toffaletti DL; Franke KS; Bartuska A; Smilnak G; de Castro GC; Ripple K; Hope WW; Perfect JR
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31209006
[No Abstract] [Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of fluconazole for cryptococcal meningoencephalitis: implications for antifungal therapy and in vitro susceptibility breakpoints.
Sudan A; Livermore J; Howard SJ; Al-Nakeeb Z; Sharp A; Goodwin J; Gregson L; Warn PA; Felton TW; Perfect JR; Harrison TS; Hope WW
Antimicrob Agents Chemother; 2013 Jun; 57(6):2793-800. PubMed ID: 23571544
[TBL] [Abstract][Full Text] [Related]
3. Experimental Models of Short Courses of Liposomal Amphotericin B for Induction Therapy for Cryptococcal Meningitis.
Lestner J; McEntee L; Johnson A; Livermore J; Whalley S; Schwartz J; Perfect JR; Harrison T; Hope W
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320715
[TBL] [Abstract][Full Text] [Related]
4. Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance.
Hope W; Stone NRH; Johnson A; McEntee L; Farrington N; Santoro-Castelazo A; Liu X; Lucaci A; Hughes M; Oliver JD; Giamberardino C; Mfinanga S; Harrison TS; Perfect JR; Bicanic T
mBio; 2019 Dec; 10(6):. PubMed ID: 31796539
[TBL] [Abstract][Full Text] [Related]
5. Isavuconazole Is Effective for the Treatment of Experimental Cryptococcal Meningitis.
Wiederhold NP; Kovanda L; Najvar LK; Bocanegra R; Olivo M; Kirkpatrick WR; Patterson TF
Antimicrob Agents Chemother; 2016 Sep; 60(9):5600-3. PubMed ID: 27324761
[TBL] [Abstract][Full Text] [Related]
6. Repurposing and Reformulation of the Antiparasitic Agent Flubendazole for Treatment of Cryptococcal Meningoencephalitis, a Neglected Fungal Disease.
Nixon GL; McEntee L; Johnson A; Farrington N; Whalley S; Livermore J; Natal C; Washbourn G; Bibby J; Berry N; Lestner J; Truong M; Owen A; Lalloo D; Charles I; Hope W
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29311092
[TBL] [Abstract][Full Text] [Related]
7. Limited activity of miltefosine in murine models of cryptococcal meningoencephalitis and disseminated cryptococcosis.
Wiederhold NP; Najvar LK; Bocanegra R; Kirkpatrick WR; Sorrell TC; Patterson TF
Antimicrob Agents Chemother; 2013 Feb; 57(2):745-50. PubMed ID: 23165465
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamics of liposomal amphotericin B and flucytosine for cryptococcal meningoencephalitis: safe and effective regimens for immunocompromised patients.
O'Connor L; Livermore J; Sharp AD; Goodwin J; Gregson L; Howard SJ; Felton TW; Schwartz JA; Neely MN; Harrison TS; Perfect JR; Hope WW
J Infect Dis; 2013 Jul; 208(2):351-61. PubMed ID: 23599314
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamics of isavuconazole in experimental invasive pulmonary aspergillosis: implications for clinical breakpoints.
Kovanda LL; Petraitiene R; Petraitis V; Walsh TJ; Desai A; Bonate P; Hope WW
J Antimicrob Chemother; 2016 Jul; 71(7):1885-91. PubMed ID: 27084921
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans.
Perfect JR; Cox GM; Dodge RK; Schell WA
Antimicrob Agents Chemother; 1996 Aug; 40(8):1910-3. PubMed ID: 8843302
[TBL] [Abstract][Full Text] [Related]
11. Measurement of antifungal drug levels in cerebrospinal fluid for cryptococcal meningoencephalitis.
Shoji H; Takuma T; Ohbayashi H; Yoshida K; Yamamoto T; Niki Y
J Infect Chemother; 2012 Oct; 18(5):775-9. PubMed ID: 22318291
[TBL] [Abstract][Full Text] [Related]
12. The Fungal Cyp51 Inhibitor VT-1129 Is Efficacious in an Experimental Model of Cryptococcal Meningitis.
Wiederhold NP; Najvar LK; Garvey EP; Brand SR; Xu X; Ottinger EA; Alimardanov A; Cradock J; Behnke M; Hoekstra WJ; Schotzinger RJ; Jaramillo R; Olivo M; Kirkpatrick WR; Patterson TF
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987152
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamics of ATI-2307 in a rabbit model of cryptococcal meningoencephalitis.
Giamberardino CD; Tenor JL; Toffaletti DL; Palmucci JR; Schell W; Boua J-VK; Marius C; Stott KE; Steele SL; Hope W; Cilla D; Perfect JR
Antimicrob Agents Chemother; 2023 Oct; 67(10):e0081823. PubMed ID: 37728934
[TBL] [Abstract][Full Text] [Related]
14. Impact of Mucositis on Absorption and Systemic Drug Exposure of Isavuconazole.
Kovanda LL; Marty FM; Maertens J; Desai AV; Lademacher C; Engelhardt M; Lu Q; Hope WW
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28289034
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo efficacies of the new triazole albaconazole against Cryptococcus neoformans.
Miller JL; Schell WA; Wills EA; Toffaletti DL; Boyce M; Benjamin DK; Bartroli J; Perfect JR
Antimicrob Agents Chemother; 2004 Feb; 48(2):384-7. PubMed ID: 14742184
[TBL] [Abstract][Full Text] [Related]
16.
Shaw KJ; Schell WA; Covel J; Duboc G; Giamberardino C; Kapoor M; Moloney M; Soltow QA; Tenor JL; Toffaletti DL; Trzoss M; Webb P; Perfect JR
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891599
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis.
Lu R; Hollingsworth C; Qiu J; Wang A; Hughes E; Xin X; Konrath KM; Elsegeiny W; Park YD; Atakulu L; Craft JC; Tramont EC; Mannino R; Williamson PR
mBio; 2019 May; 10(3):. PubMed ID: 31138748
[No Abstract] [Full Text] [Related]
18. CD4
Neal LM; Xing E; Xu J; Kolbe JL; Osterholzer JJ; Segal BM; Williamson PR; Olszewski MA
mBio; 2017 Nov; 8(6):. PubMed ID: 29162707
[No Abstract] [Full Text] [Related]
19. A multi-arm, parallel, preclinical study investigating the potential benefits of acetazolamide, candesartan, and triciribine in combination with fluconazole for the treatment of cryptococcal meningoencephalitis.
Alanazi AH; Chastain DB; Rudraraju M; Parvathagiri V; Shan S; Lin X; Henao-Martínez AF; Franco-Paredes C; Narayanan SP; Somanath PR
Eur J Pharmacol; 2023 Dec; 960():176177. PubMed ID: 37931839
[TBL] [Abstract][Full Text] [Related]
20. Cryptococcal meningoencephalitis diagnosed by blood culture.
Sivasangeetha K; Harish BN; Sujatha S; Parija SC; Dutta TK
Indian J Med Microbiol; 2007 Jul; 25(3):282-4. PubMed ID: 17901653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
